FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/08/2023
Voltar para busca
Dado oficial do USPTO
PIONEER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PIONEER
ST13
US500000079329052Classe
1, 5, 40, 42
Pedido
79329052
Registro
7021191
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
14/08/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42
Data de depósito
06/10/2021
Data de registro
11/04/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/04/2023
Última transação
11/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CH
Examinador
MALYSZEK, KIMBERLY
Unidade examinadora
O30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Bio-Rad Europe GmbH
Bio-Rad Laboratories GmbH
Representantes
Margaret C. McHugh Kilpatrick Townsend & Stockton LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and sciencediagnostic kits consisting primarily of antibodies and reagents for use in disease testing; biological preparations in the nature of antibodies for research useother than for medical or veterinary purposes; antibody librariesfor scientificindustrial or research usebiological preparations in the nature of antibodies sold together; libraries of immunoglobulinsantibodiesfragments thereoffor scientificindustrialresearch usebiological preparations in the nature of immunoglobulinsantibodiesfragments thereof sold together as a kit; biological preparations in the nature of immunoglobulinsantibodiesfragments thereoffor scientificindustrialresearch use; assays and reagents for use in genetic research; diagnostic reagents for scientific and research use; reagents and kits comprising chemical reagentsboth for scientific or research use in the field of diagnosing diseases
Classe 5
Biological preparations for the treatment of infectious diseasesdeficiency diseaseshereditary diseasesphysiological diseases; pharmaceuticalbiopharmaceutical and medical preparations for the treatment of infectious diseasesdeficiency diseaseshereditary diseasesphysiological diseases; diagnostic preparations for medical purposes; antibodies for medical purposes; biological preparationsimmunoglobulinsantibodiesfragments thereoffor medical use; antibody librariesfor medical and veterinary usecollections of antibodies for medical purposes; libraries of immunoglobulinsantibodiesfragments thereoffor medical usecollections of biological preparations in the nature of immunoglobulinsantibodiesfragments thereoffor medical usesold as a unit; biological preparations comprised of immunoglobulinsantibodiesfragments thereoffor use in medicine; diagnostic reagents for medical purposes; diagnostic reagents for medical use; diagnostic reagents for medical clinician or medical use
Classe 40
Antibody production for othersmanufacture of antibodies for others; custom manufacture of antibodiesantibody purificationantibody fragmentation; custom production of cell cultures and biological products in the nature of antibodies and proteins and related reagents; custom antibody production; custom manufacturing for othersmanufacturing of chemical and biotechnological materials for othersmanufacturing of organismscompounds and materials for use in the pharmaceuticalagrochemicalchemicalbiotechnology industries
Classe 42
Research and development in the field of antibody generation services; medical and scientific research for the identificationpreparationdevelopment of antibody libraries; Chemicalbiochemicalbiological and bacteriological research and analysis services in the nature of preparation and screening of libraries of proteins and antibodieslibraries of cells producing antibodies and proteinslibraries of vector coding for antibodies and proteins; design of antibody libraries for medical or veterinary use; scientific and technological servicesscientific and technological researchanalysisinspectionquality auditconsultingdesignengineeringdevelopment and laboratory testing services for others; research and development services in the field of developing new chemicals; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto; providing information and consultancy on testinginspection or research of pharmaceuticalschemicals for use in medicinesreagents for use in medicinescosmetics or foodstuffs; scientific or laboratory testinginspection or research of nucleic acidschemicals and pharmaceuticals for drug development and medical research purposesproviding scientific information and research consultancy relating thereto; genomic experimentsanalysesresearchassaystestsinspectiondetection or verificationscientific laboratory services being scientific genomic analysesscientific genomic researchcustom design and development of biochemical genomic assaysgenome amplification and functional and structural analysis of genomes; scientific laboratory services of a chemistbiologistbiochemistbiotechnologistsgene technologistsmolecular biologistspharmacistsprotein chemist; chemical and biological analysis and research services; pharmaceuticalmedicalscientific and biopharmaceutical research and development; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/07/2023
FIMP
FINAL DISPOSITION PROCESSED
26/07/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2023
GPNX
NOTIFICATION PROCESSED BY IB
24/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/01/2023
PUBO
PUBLISHED FOR OPPOSITION
24/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/01/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/12/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
20/12/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/12/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
20/12/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/12/2022
RFNT
REFUSAL PROCESSED BY IB
19/07/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/06/2022
RFRR
REFUSAL PROCESSED BY MPU
25/06/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/06/2022
CNRT
NON-FINAL ACTION WRITTEN
16/06/2022
DOCK
ASSIGNED TO EXAMINER
15/06/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/06/2022
MAFR
APPLICATION FILING RECEIPT MAILED
04/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PIONEER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.